Broussonetia papyrifera pollen is an extract from Broussonetia papyrifera pollen used in allergy testing.
- First approval
- United States, 1967
- Also known as
- mulberry pollen extract
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of April 02, 2025
Which other approved drugs treat the same conditions as Broussonetia papyrifera pollen, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account